UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer

Authors

Carey K Anders, MD

Assistant Professor

University of North Carolina - Chapel Hill

Lineberger Cancer Center

Lisa A Carey, MD

Professor of Medicine

University of North Carolina

Lineberger Comprehensive Cancer Center

Section Editor

Daniel F Hayes, MD

Section Editor — Breast Cancer

Professor of Medicine

University of Michigan School of Medicine

Deputy Editor

Sadhna R Vora, MD

Deputy Editor — Oncology

Instructor in Medicine

Harvard Medical School

Peer Reviewer

Reviewers are not identified on topic reviews to preserve anonymity